Major League Baseball is set to introduce the Automated Ball-Strike Challenge System (ABS) this season. And with it, there will be some changes to both the in-stadium experience and the at-home ...

TechRadar Pro created this content as part of a paid partnership with RS. The content of this article is entirely independent and solely reflects the editorial opinion of TechRadar Pro. You've ...

A team of theoretical researchers has found duality can unveil non-invertible symmetry protected topological phases, which can lead to researchers understanding more about the properties of these ...

LAS VEGAS--(BUSINESS WIRE)--Dot Ai (Nasdaq: DAIC) (“Dot Ai” or the “Company”), an IoT and AI-based SaaS company redefining asset intelligence for industrial technology, today announced it will ...

Soon, the safety regulations that keep airplanes in the sky, car passengers safe, and prevent gas pipelines from exploding, might be written by AI. This concerns some people in the Transportation ...

The US Department of Transportation apparently thinks it’s a good idea to use artificial intelligence to draft rules impacting the safety of airplanes, cars, and pipelines, a ProPublica investigation ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. The Trump administration is planning to use artificial ...

The Echo Dot is one of Amazon's most affordable smart hubs, and while it doesn't pack the most powerful speaker and isn't as feature-rich as the Echo Studio, it's a neat little way to enjoy the Alexa ...

Per the terms of the agreement, Novavax will receive an upfront payment of $30 million from Pfizer and is eligible to earn up to $500 million in potential development and commercial milestone payments ...

Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...